Protocol: Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium (18 March, 2024)
Toon Van Genechten, Maxime De Laere, Jolien Van den Bossche, Barbara Stein, kim De Rycke, Caroline Deschepper, Katja Hazes, Renke Peeters, Marie-Madeleine Couttenye, Katrien Van De Walle, Ella Roelant, Sabine Maes, Stephanie Vanden Bossche, Sven Dekeyzer, Manon Huizing, Kim Caluwaert, Griet Nijs, Nathalie Cools, Joris Verlooy, Koen Norga, Stijn Verhulst, Sebastien Anguille, Zwi Berneman, Eva Lion